FDA Approval Insights: Zanubrutinib in CLL and SLL

Season 8, Episode 21,   Feb 16, 2023, 08:15 PM

Headliner
Share
Subscribe
Drs Flinn, Lamanna, Brown, and Tam discuss the FDA approval of zanubrutinib in chronic lymphocytic leukemia and small lymphocytic lymphoma.
Share
Subscribe
Next
Mascarenhas Summarizes Therapeutic Standards and Advances in Myelofibrosis Management
Top episodes
FDA Approval Insights: Amivantamab and Mobocertinib in EGFR Exon 20 Insertion+ NSCLC
by OncLive® On Air
Milhem Talks Mechanism of Action, Delivery Methodology, and Ongoing Trials With RP1
by OncLive® On Air
Wise Summarizes Survival Data From ARASENS and PEACE-1 in Prostate Cancer
by OncLive® On Air